Cogstate (CGS)

Download button icon Download

Cogstate (CGS): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

Cogstate (CGS.AX)


Indicator:

VOLUME MACD


Last Signal:

BULLISH


Trading: HOLD @ $0.59
Signal Strength: MEDIUM
Recommendation:

Cogstate (ASX:CGS) currently has positive Volume MACD of 4665. This means the signal line is greater than the Volume MACD line signalling a bullish movement.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement


Volume Moving Average Convergence/Divergence (VMACD) is an indicator that shows the relationship between two moving averages. It is calculated as a difference between the fast and slow moving averages. The historically popular is the difference between a securities 26-day and 12-day Exponential Moving Averages (EMA).

Calculation: Moving Average Convergence Divergence Volume (VMACD):
1) VMACD Line: (12-day EMA - 26-day EMA);
2) Signal Line: 9-day EMA of VMACD Line;
3) VMACD Histogram: VMACD Line - Signal Line;


PROFILE: Cogstate (CGS.AX)


Stock Exchange: ASX
Company: Cogstate
Ticker Codes: | CGS.AX | ASX:CGS |

About Cogstate (ASX:CGS):

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications primarily in Australia, the United States, and Europe. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations. As of June 30, 2017, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system that enables regular and standardized assessment of patients to detect cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.

Top 10:

MACD Volume

Download button icon Download
Company Close Change (%) Volume Value Signal
DNA Donaco International 0.07 89.2 89,678,822 6,804,800 BULLISH
CUV Clinuvel Pharmaceuticals 17.98 9.6 39,812 8,661 BULLISH
RAP Resapp Health 0.12 9.5 648,223 62,462 BULLISH
IRI Integrated Research 1.72 7.5 989,647 42,192 BULLISH
IFL Ioof Holdings 4.83 7.3 4,622,897 610,138 BULLISH
NTC Netcomm 0.73 6.6 269,340 13,506 BULLISH
KSC K&S Corporation 1.46 6.6 5,143 231 BULLISH
MOY Millennium Minerals 0.19 5.7 282,159 80,373 BULLISH
AJM Altura Mining 0.19 5.7 2,026,441 36,483 BULLISH
ABC Adelaide Brighton 4.57 5.3 2,801,167 242,094 BULLISH
back to top